Valued at USD 312.62 million in 2025, the Residual DNA Testing Market is expected to reach USD 329.66 million in 2026 and USD 519.69 million by 2034, expanding at a CAGR of 5.9% during the forecast period 2026–2034. Rising biologics manufacturing and vaccine manufacturing, along with increasing regulatory focus on product safety, are the principal drivers. North America led in 2025 with a...